This inventor holds 1 USPTO granted patent. Top assignee: Uchicago Argonne, LLC. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Lee A Solomon: Innovator in Anti-Inflammatory Regenerative Nanobiomedicine
Introduction
Lee A Solomon is a prominent inventor based in Chicago, IL (US). She has made significant contributions to the field of nanobiomedicine, particularly in developing innovative solutions for anti-inflammatory applications. Her work focuses on utilizing peptide materials to address the challenges posed by heme toxicity and inflammation.
Latest Patents
Lee A Solomon holds a patent for "Heme peptide materials for anti-inflammatory regenerative nanobiomedicine." This patent addresses the toxicity caused by heme released during sustained injury, which triggers an inflammatory response and tissue damage. The invention involves peptide amphiphiles that mimic the function of heme oxygenase, an enzyme that binds and breaks down free heme as part of the anti-inflammatory response. The designed peptides have demonstrated the ability to bind and degrade heme, validating their potential as anti-inflammatory agents that promote tissue repair and are useful in wound healing. The disclosed peptide sequence design allows for control over the supramolecular structure and function of the amphiphile peptides. Additionally, the incorporated heme molecule can transport carbon monoxide (CO), suggesting that these peptides may also transport nitric oxide (NO), oxygen, and reactive oxygen species, which are crucial for vasodilation, neurotransmission, and cell death. Furthermore, the peptides are believed to recognize normal tissue adjacent to damaged areas and can self-assemble into fibers that promote healthy cell growth.
Career Highlights
Lee A Solomon is affiliated with UChicago Argonne, LLC, where she continues her research and development in the field of nanobiomedicine. Her innovative work has positioned her as a key figure in advancing therapeutic strategies for inflammation and tissue repair.
Collaborations
Lee collaborates with Harry C Fry, contributing to the advancement of their shared research interests in nanobiomedicine and peptide technology.
Conclusion
Lee A Solomon's contributions to anti-inflammatory regenerative nanobiomedicine highlight her innovative spirit and dedication to improving health outcomes. Her patented work on heme peptide materials showcases the potential of peptide technology in addressing critical medical challenges.